These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 24839832)

  • 21. Identification of novel Bruton's tyrosine kinase mutations in 10 unrelated subjects with X linked agammaglobulinaemia.
    Brooimans RA; van den Berg AJ; Rijkers GT; Sanders LA; van Amstel JK; Tilanus MG; Grubben MJ; Zegers BJ
    J Med Genet; 1997 Jun; 34(6):484-8. PubMed ID: 9192269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of nine novel mutations in the Bruton's tyrosine kinase gene in X-linked agammaglobulinaemia patients.
    Orlandi P; Ritis K; Moschese V; Angelini F; Arvanitidis K; Speletas M; Sideras P; Plebani A; Rossi P
    Hum Mutat; 2000 Jan; 15(1):117. PubMed ID: 10612838
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel Bruton's tyrosine kinase gene (BTK) invariant splice site mutation in a Malaysian family with X-linked agammaglobulinemia.
    Chear CT; Gill HK; Ramly NH; Dhaliwal JS; Bujang N; Ripen AM; Mohamad SB
    Asian Pac J Allergy Immunol; 2013 Dec; 31(4):320-4. PubMed ID: 24383975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bruton's tyrosine kinase mutations in 8 Chinese families with X-linked agammaglobulinemia.
    Yip KL; Chan SY; Ip WK; Lau YL
    Hum Mutat; 2000 Apr; 15(4):385. PubMed ID: 10737994
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Delayed diagnosis of X-linked agammaglobulinaemia in a boy with recurrent meningitis.
    Zhang YN; Gao YY; Yang SD; Cao BB; Zheng KL; Wei P; Chen LF; Chen WX
    BMC Neurol; 2019 Dec; 19(1):320. PubMed ID: 31830942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of a new Bruton's tyrosine kinase (BTK) mutation associated with a mild phenotype in a child with X-linked agammaglobulinemia (XLA).
    Staehelin F; Kühne T
    Clin Lab Haematol; 2000 Apr; 22(2):123-5. PubMed ID: 10792406
    [TBL] [Abstract][Full Text] [Related]  

  • 27. X-chromosome inactivation and mutation pattern in the Bruton's tyrosine kinase gene in patients with X-linked agammaglobulinemia. Italian XLA Collaborative Group.
    Moschese V; Orlandi P; Plebani A; Arvanitidis K; Fiorini M; Speletas M; Mella P; Ritis K; Sideras P; Finocchi A; Livadiotti S; Rossi P
    Mol Med; 2000 Feb; 6(2):104-13. PubMed ID: 10859027
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BTK: 22 novel and 25 recurrent mutations in European patients with X-linked agammaglobulinemia.
    Fiorini M; Franceschini R; Soresina A; Schumacher RF; Ugazio AG; Rossi P; Plebani A; Notarangelo LD
    Hum Mutat; 2004 Mar; 23(3):286. PubMed ID: 14974089
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of Btk mutations in patients with X-linked agammaglobulinaemia (XLA) and determination of carrier status in normal female relatives: a nationwide study of Btk deficiency in Greece.
    Speletas M; Kanariou M; Kanakoudi-Tsakalidou F; Papadopoulou-Alataki E; Arvanitidis K; Pardali E; Constantopoulos A; Kartalis G; Vihinen M; Sideras P; Ritis K
    Scand J Immunol; 2001 Sep; 54(3):321-7. PubMed ID: 11555397
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Novel
    Han SP; Lin YF; Weng HY; Tsai SF; Fu LS
    Front Immunol; 2019; 10():1953. PubMed ID: 31481959
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening of genomic DNA to identify mutations in the gene for Bruton's tyrosine kinase.
    Conley ME; Fitch-Hilgenberg ME; Cleveland JL; Parolini O; Rohrer J
    Hum Mol Genet; 1994 Oct; 3(10):1751-6. PubMed ID: 7849697
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimizing Integration and Expression of Transgenic Bruton's Tyrosine Kinase for CRISPR-Cas9-Mediated Gene Editing of X-Linked Agammaglobulinemia.
    Gray DH; Villegas I; Long J; Santos J; Keir A; Abele A; Kuo CY; Kohn DB
    CRISPR J; 2021 Apr; 4(2):191-206. PubMed ID: 33876953
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical features and mutational analysis of X-linked agammaglobulinemia patients in Malaysia.
    Chear CT; Ismail IH; Chan KC; Noh LM; Kassim A; Latiff AHA; Gill SS; Ramly NH; Tan KK; Sundaraj C; Choo CM; Mohamed SAS; Baharin MF; Zamri AS; Yahya SNHS; Mohamad SB; Ripen AM
    Front Immunol; 2023; 14():1252765. PubMed ID: 37809070
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of BTK mutations in male Algerian patterns with agammaglobulinemia and severe B cell lymphopenia.
    Boushaki S; Tahiat A; Meddour Y; Chan KW; Chaib S; Benhalla N; Smati L; Bensenouci A; Lau YL; Magdinier F; Djidjik R
    Clin Immunol; 2015 Dec; 161(2):286-90. PubMed ID: 26387629
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical characteristics and molecular analysis of 21 Chinese children with congenital agammaglobulinemia.
    Zhang ZY; Zhao XD; Jiang LP; Liu EM; Wang M; Yu J; Liu P; Yang XQ
    Scand J Immunol; 2010 Nov; 72(5):454-9. PubMed ID: 21039741
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical characteristics and genetic profiles of 174 patients with X-linked agammaglobulinemia: Report from Shanghai, China (2000-2015).
    Chen XF; Wang WF; Zhang YD; Zhao W; Wu J; Chen TX
    Medicine (Baltimore); 2016 Aug; 95(32):e4544. PubMed ID: 27512878
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bruton tyrosine kinase (BTK) in X-linked agammaglobulinemia (XLA).
    Vihinen M; Mattsson PT; Smith CI
    Front Biosci; 2000 Dec; 5():D917-28. PubMed ID: 11102316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kinase mutant Btk results in atypical X-linked agammaglobulinaemia phenotype.
    Gaspar HB; Ferrando M; Caragol I; Hernandez M; Bertran JM; De Gracia X; Lester T; Kinnon C; Ashton E; Espanol T
    Clin Exp Immunol; 2000 May; 120(2):346-50. PubMed ID: 10792386
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Six X-linked agammaglobulinemia-causing missense mutations in the Src homology 2 domain of Bruton's tyrosine kinase: phosphotyrosine-binding and circular dichroism analysis.
    Mattsson PT; Lappalainen I; Bäckesjö CM; Brockmann E; Laurén S; Vihinen M; Smith CI
    J Immunol; 2000 Apr; 164(8):4170-7. PubMed ID: 10754312
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and genetic profiles of patients with X-linked agammaglobulinemia from southeast Turkey: Novel mutations in BTK gene.
    Doğruel D; Serbes M; Şaşihüseyinoğlu AŞ; Yılmaz M; Altıntaş DU; Bişgin A
    Allergol Immunopathol (Madr); 2019; 47(1):24-31. PubMed ID: 30072168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.